AXS-05, an investigational modulated-delivery tablet combining dextromethorphan and bupropion, significantly improved symptoms of depression in patients with major depressive disorder (MDD) in a recent phase 3 trial, announced developer Axsome Therapeutics Inc.
Having a parent with depression was associated with structural differences in the brains of 9- and 10-year-olds, according to a study published online in the Journal of the American Academy of Child & Adolescent Psychiatry.
Approximately 20% of people with major depressive disorder (MDD) experienced high or fluctuating suicidal ideation over 12 weeks of treatment with antidepressants, researchers found in a study published in The Journal of Clinical Psychiatry.
Knowing someone with emotional or mental health problems increased the likelihood that people who screened positive for depression sought out depression treatment for themselves, according to a study published online in Psychiatric Services.
A meta-analysis recently published in The Lancet Psychiatry found that using medicinal cannabinoids to treat mental health disorders cannot be justified, due to a lack of evidence of effectiveness and known risks of the substances.